You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 5, 2026

Drug Price Trends for ZATEAN-PN DHA CAPSULE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ZATEAN-PN DHA CAPSULE

Average Pharmacy Cost for ZATEAN-PN DHA CAPSULE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ZATEAN-PN DHA CAPSULE 13811-0580-30 0.92409 EACH 2026-03-18
ZATEAN-PN DHA CAPSULE 13811-0580-30 0.95312 EACH 2026-02-18
ZATEAN-PN DHA CAPSULE 13811-0580-30 0.99818 EACH 2026-01-21
ZATEAN-PN DHA CAPSULE 13811-0580-30 1.00653 EACH 2025-12-17
ZATEAN-PN DHA CAPSULE 13811-0580-30 0.97137 EACH 2025-11-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for ZATEAN-PN DHA Capsule

Last updated: February 23, 2026

What is the Current Market Landscape for DHA Capsules?

The global dietary supplements market, particularly for omega-3 and DHA (docosahexaenoic acid) capsules, is expanding rapidly. The increasing awareness of cognitive, cardiovascular, and prenatal health benefits propels demand.

  • Market Size: The omega-3 market was valued at approximately $4.4 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 8% through 2028.[1]
  • Key Players: Major players include GNC, Nature Made, Nordic Naturals, and DSM, which are competing through product differentiation, quality certifications, and positioning in premium segments.
  • Regulatory Environment: Countries like the U.S. and Canada regulate DHA supplements as foods or dietary supplements, not pharmaceuticals. Strict labeling and health claim regulations influence market strategies.

How Does ZATEAN-PN DHA Capsule Position in This Market?

ZATEAN-PN DHA capsules target prenatal and neurodegenerative markets, emphasizing purity, bioavailability, and clinical backing.

  • Target Segments: Pregnant women, infants, and elderly populations with cognitive decline.
  • Advantages: Potentially higher bioavailability due to formulation technology, and possibly differentiated dosing or delivery mechanisms.
  • Market Penetration: Limited availability in mainstream retail channels; primarily sold through specialty health stores and online platforms.

What are the Price Points and Pricing Strategies Currently Observed?

Pricing varies by brand, dosage, and formulation quality.

Brand Typical Price per 60-capsule Bottle Price Range Notes
Nature Made DHA $15 $14–$17 USP-verified, mass-market, mainstream brand
Nordic Naturals $28 $26–$30 Premium quality, high EPA/DHA ratio
GNC Fish Oil $20 $18–$22 Retailer brand, moderate pricing
ZATEAN-PN DHA Unknown Estimated $25–$35 Positioned as a premium or clinical-grade product

Note: ZATEAN-PN DHA's current price remains unconfirmed publicly but is projected between $25 and $35 per bottle, considering production costs, formulation complexity, and target demographic positioning.

What Factors Influence Future Price Trends?

Several factors will shape ZATEAN-PN DHA capsule prices:

  • Manufacturing Costs: Quality control, raw material sourcing, and proprietary formulation influence the cost base.
  • Regulatory Changes: Stricter health claim regulations could impact marketing and pricing strategies.
  • Market Competition: Entry of new entrants or generic versions may drive prices downward.
  • Clinical Validation: Strong peer-reviewed studies supporting efficacy can justify premium pricing.
  • Distribution Channels: Greater online direct-to-consumer sales can lower retail margins and influence price points.

What Are Projected Price Trends?

Based on current market dynamics and product positioning:

  • Short-Term (1–2 years): Prices may stabilize around $25–$30 per 60-capsule bottle, aligning with premium competitors. Promotional offers or bundle discounts are typical.
  • Medium-Term (3–5 years): With increased competition and potential generics, prices could decrease to $20–$25, especially if manufacturing costs decline or patent exclusivity ends.
  • Long-Term (5+ years): As market matures and demand stabilizes, prices may settle at $15–$22 for equivalent quality products, assuming moderate inflation.

What Are Investment and Strategic Considerations?

For companies and investors considering ZATEAN-PN DHA:

  • Emphasize clinical data to justify premium pricing.
  • Build strong branding in prenatal health markets.
  • Secure supply chains for high-quality omega-3 sources.
  • Explore FDA and international regulatory pathways to support claims.

Key Takeaways

  • The global DHA supplement market is growing at a CAGR of around 8%, driven by health awareness in wellness and medical segments.
  • ZATEAN-PN DHA capsule aims for a premium segment, with prices estimated between $25 and $35.
  • Competitive pressures and regulatory shifts are likely to influence prices downward over the next five years.
  • Strategic focus on clinical validation and targeted marketing can support sustained premium pricing.
  • Long-term price stabilization may occur around $15–$22, assuming market maturation.

FAQs

1. What makes ZATEAN-PN DHA capsule different from other DHA supplements?
It emphasizes proprietary formulation technology, possibly higher bioavailability, and clinical backing aimed at prenatal and neurodegenerative markets.

2. How does regulatory status impact pricing?
If ZATEAN-PN DHA gains regulatory approval or health claim substantiation, it can command higher prices due to increased consumer trust.

3. What is the growth outlook for DHA supplement sales?
The market is projected to grow at 8% CAGR through 2028, supported by increasing consumer awareness and expanding applications.

4. Will price reductions be inevitable?
Competitive pressures and entry of generics could lower prices, especially beyond the initial launch phase.

5. How should companies position ZATEAN-PN DHA to maximize profitability?
Invest in clinical validation, build brand recognition in targeted markets, and optimize distribution channels to support premium pricing.


References
[1] Grandview Research. (2022). Omega-3 Fatty Acids Market Size, Share & Trends Analysis.
[2] U.S. Food and Drug Administration. (2022). Regulations for Dietary Supplements.
[3] Statista. (2023). Global Dietary Supplements Market Revenue Forecast.
[4] MarketWatch. (2023). Omega-3 Market Outlook and Industry Trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.